Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001519692-23-000008

Chief Financial Officer sold 649 shares at an average $12.94 ($8,396)

From the SEC's structured data for this filing

Trades in this filing

Greenstein Leonard M. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-17 Sale : show line 1 in the form −316 $13.28 $4,196 33,122 D
2023-03-20 Sale : show line 2 in the form −333 $12.61 $4,199 32,789 D
Open-market sales · 649 sh · avg $12.94 · $8,396
Loading xslF345X04/wf-form4_167943982457262.xml…